Federal contract award
HHSO100201600009C
CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541711 |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $185.2M |
| Current contract value | $197.5M |
| Potential contract value / ceiling | $282.2M |
| Start date | Jun 17, 2016 |
| Current end date | Mar 31, 2027 |
| Potential end date | Mar 31, 2027 |
| Latest award activity | Jul 8, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 33 of 33 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 8, 2026 | P00032 | $0 | EXTEND THE BASE (CLIN 0001) AND OPTION 1 (CLIN 0002) PERIOD OF PERFORMANCE THROUGH 31 MARCH 2027 TO ALLOW COMPLETION OF THE REMAINING EFFORT WITHOUT INCREASING THE CONTRACT VALUE. TRANSFER GOVERNMENT-FURNISHED EQUIPMENT (GFE) FROM CONTRACT HHSO100201 |
| May 18, 2026 | P00031 | $-279.7K | THE PURPOSE OF THIS MODIFICATION IS TO DEOBLIGATE FUNDS FROM CLIN 0011 (OPTION 10) AND UPDATE FAR & HHSAR CLAUSES PER EXECUTIVE ORDER AND FAR/HHSAR CLASS DEVIATIONS |
| Feb 20, 2026 | P00030 | $0 | THE PURPOSE OF THIS NO COST MODIFICATION IS TO ADMINISTRATIVELY CORRECT THE CONTRACT CLINS PERIOD OF PERFORMANCE IN THE PRISM CONTRACT WRITING SYSTEM IN ORDER TO ALIGN IT FOR INVOICING. |
| Sep 21, 2025 | P00029 | $0 | THE PURPOSE OF THIS MODIFICATION: 1. NO COST EXTENSION FOR OPTION 01 (CLIN 0002), 2. REVISE KEY PERSONNEL, AND 3. REVISE THE STATEMENT OF WORK. |
| Dec 13, 2024 | P00028 | $0 | NO COST EXTENSION FOR OPTION 16 (CLIN 0018) AND REVISE KEY PERSONNEL. |
| Jun 13, 2024 | P00027 | $-2 | MODIFICATION TO DE-OBLIGATE CANCELING FUNDS AND REVISE KEY PERSONNEL. |
| Dec 14, 2023 | P00026 | $0 | NO COST MODIFICATION TO EXTEND THE PERIOD OF PERFORMANCE FOR CLIN 05 OPTION PERIOD 04. |
| Sep 12, 2023 | P00025 | $3.5M | EXERCISE OPTION PERIOD 16. |
| Mar 30, 2023 | P00024 | $0 | EXTEND PERIODS OF PERFORMANCE FOR THE IPP INVOICING SYSTEM. |
| Mar 15, 2023 | P00023 | $33.0M | SUPPLEMENTAL FUNDING FOR BASE PERIOD AND OPTION PERIOD 5. |
| Jan 24, 2023 | P00022 | $0 | CERUS - NO-COST EXTENSION AND REVISION OF STATEMENT OF WORK. |
| Sep 27, 2022 | P00021 | $-575.7K | CERUS - DE-OBLIGATION OF EXPIRING FUNDS. |
| Sep 9, 2022 | P00020 | $0 | CERUS - NO COST EXTENSION TO CORRECT CLINS PERIOD OF PERFORMANCES FOR IPP INVOICING SYSTEM. |
| Sep 1, 2022 | P00019 | $0 | CERUS - NO COST EXTENSION OF CLIN 0001 BASE PERIOD AND CLIN 0006 OPTION PERIOD 5. |
| Jun 15, 2022 | P00018 | $23.0M | CERUS - SUPPLEMENTAL FUNDING OPTION 1 (CLIN0002) AND OPTION 3 (CLIN0004). |
| May 18, 2022 | P00017 | $0 | CERUS - REVISE POP DATES FOR IPP. |
| May 9, 2022 | P00016 | $0 | CERUS - REVISE POP DATES FOR IPP. |
| Mar 23, 2022 | P00015 | $0 | NO COST POP EXTENSION FOR CLIN 0002 AND ADD HHSAR CLAUSE AT 352.232-71, ELECTRONIC SUBMISSION OF PAYMENT REQUESTS. |
| Dec 30, 2021 | P00014 | $0 | DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT) |
| Nov 29, 2021 | P00013 | $0 | DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT) |
| Jun 30, 2021 | P00012 | $9.6M | DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT) |
| Apr 18, 2020 | P00011 | $13.8M | THIS MODIFICATION 11 (ELEVEN) ACCOMPLISHES THE FOLLOWING: 1.) SUPPLEMENTAL FUNDING IN THE AMOUNT OF $12,736,273 PROVIDED FOR BASE PERIOD (CLIN 0001) 2.) PERIOD OF PERFORMANCE OF BASE PERIOD (CLIN 0001 - A AND B) IS EXTENDED FROM 6/30/2020 TO 6/30 |
| Mar 16, 2020 | P00010 | $0 | THIS MODIFICATION 10 (TEN) ACCOMPLISHES THE FOLLOWING: 1.) EXTENDS THE END DATE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT OF CLIN 0001 (BASE) AND CLIN 2 (OPTION 1) FROM TO 6/30/2020. |
| Nov 20, 2019 | P00009 | $0 | THIS MODIFICATION 9 (NINE) ACCOMPLISHES THE FOLLOWING: 1.) REPLACES THE STATEMENT OF WORK (SECTION J ? ATTACHMENT 1) IN ITS ENTIRETY WITH THE VERSION DATED OCTOBER 4, 2019. 2.) EXTENDS THE PERIOD OF PERFORMANCE AT NO COST TO THE GOVERNMENT OF CLI |
| Jun 18, 2019 | P00008 | $0 | CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF |
| May 15, 2018 | 7 | $15.0M | CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF |
| Feb 27, 2018 | 6 | $0 | CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF |
| Jun 29, 2017 | 5 | $0 | CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF |
| May 8, 2017 | 4 | $46.6M | CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF |
| Mar 16, 2017 | 3 | $0 | CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF |
| Mar 12, 2017 | 2 | $0 | CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF |
| Nov 30, 2016 | 1 | $10.8M | CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF |
| Jun 17, 2016 | 0 | $30.8M | CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-03-31 (157 days from calculation)
- +35 points
- 40 historical awards in this buyer and category group
- +15 points
- 33 recorded award transactions
- +10 points
- Latest award action: 2026-07-08
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.